Immunovant, Inc.
IMVTNASDAQHealthcare● Active
$30.80
$-0.31(-1.00%)
Market Cap$6.3B
P/E Ratio—
52W High$36.285
52W Low$14.32
Immunovant, Inc.（IMVT）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IMVT · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.51B) | ($0.41B) | ($0.26B) | ($0.21B) | ($0.16B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.06B | $0.05B | $0.04B | $0.03B | $0.03B |
| Change in Working Capital | $0.04B | ($0.01B) | $0.00B | ($0.01B) | $0.02B |
| Net Cash from Operations | ($0.41B) | ($0.38B) | ($0.21B) | ($0.19B) | ($0.11B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.60B | $0.45B | $0.47B | $0.07B | $0.20B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.41B) | ($0.38B) | ($0.21B) | ($0.19B) | ($0.11B) |
| FCF Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Immunovant, Inc.
关于Immunovant, Inc.（IMVT）现金流量表
Immunovant, Inc. 2026财年经营活动现金流($0.41B)，自由现金流($0.41B)（FCF利润率—），资本支出($0.00B)。
常见问题
IMVT · 4 问Immunovant, Inc. 2026财年自由现金流($0.41B)，同比down8.1%。
IMVT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10